[Vitamin D and its therapeutic use].
D015650:24,25-Dihydroxyvitamin D 3; D000042:Absorption; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D002112:Calcifediol / Q000097:blood; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy; D004066:Digestive System Diseases / Q000150:complications; D004100:Dihydroxycholecalciferols / Q000097:blood; D005198:Fanconi Syndrome / Q000150:complications; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000378:metabolism; D006996:Hypocalcemia / Q000151:congenital / Q000188:drug therapy; D007011:Hypoparathyroidism / Q000188:drug therapy; D007015:Hypophosphatemia, Familial / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000235:genetics; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000150:complications; D007700:Kinetics; D008107:Liver Diseases / Q000150:complications; D008593:Menopause; D009369:Neoplasms / Q000150:complications; D010018:Osteomalacia / Q000188:drug therapy / Q000209:etiology; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology; D012279:Rickets / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D014807:Vitamin D / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D000927:Anticonvulsants; D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D014807:Vitamin D; D015650:24,25-Dihydroxyvitamin D 3; D002117:Calcitriol; D002112:Calcifediol; D002118:Calcium; C008088:alfacalcidol
La vitamine D et son utilisation thérapeutique.